• Home
  • About us
  • Contact us
  • DMCA
Forbes.llc
  • Home
  • Innovation
    • 5G
    • AI
    • Big Data
    • Cloud
    • Cloud 100
    • Consumer Tech
    • COP26
    • Cybersecurity
    • Enterprise Tech
    • Future Of Work
    • Games
  • Leadership
    • Careers
    • CEO Network
    • CFO Network
    • CHRO Network
    • CIO Network
    • CMO Network
    • Money
      • ETFs & Mutual Funds
      • Fintech
      • Hedge Funds & Private Equity
      • Investing
      • Investing Basic
      • Markets
      • Personal Finance
      • Premium Investing Newsletters
  • Forbes Digital Assets
    • Dashboard
    • Traded Assets
    • Research
    • Events
    • Crypto Portfolios
  • Business
    • Aerospace & Defense
    • Energy
    • Food & Drink
    • Hollywood & Entertainment
    • Manufacturing
    • Media
    • Policy
  • Small Business
    • Small Business Strategy
    • Enterprise Tech
    • Franchises
  • Lifestyle
    • Arts
    • Boats & Planes
    • Cars & Bikes
    • Dining
    • Real Estate
      • Commercial Real Estate
      • Residential Real Estate
      • Forbes Global Properties
      • Vetted
No Result
View All Result
  • Home
  • Innovation
    • 5G
    • AI
    • Big Data
    • Cloud
    • Cloud 100
    • Consumer Tech
    • COP26
    • Cybersecurity
    • Enterprise Tech
    • Future Of Work
    • Games
  • Leadership
    • Careers
    • CEO Network
    • CFO Network
    • CHRO Network
    • CIO Network
    • CMO Network
    • Money
      • ETFs & Mutual Funds
      • Fintech
      • Hedge Funds & Private Equity
      • Investing
      • Investing Basic
      • Markets
      • Personal Finance
      • Premium Investing Newsletters
  • Forbes Digital Assets
    • Dashboard
    • Traded Assets
    • Research
    • Events
    • Crypto Portfolios
  • Business
    • Aerospace & Defense
    • Energy
    • Food & Drink
    • Hollywood & Entertainment
    • Manufacturing
    • Media
    • Policy
  • Small Business
    • Small Business Strategy
    • Enterprise Tech
    • Franchises
  • Lifestyle
    • Arts
    • Boats & Planes
    • Cars & Bikes
    • Dining
    • Real Estate
      • Commercial Real Estate
      • Residential Real Estate
      • Forbes Global Properties
      • Vetted
Social icon element need JNews Essential plugin to be activated.
No Result
View All Result
Forbes LLC
No Result
View All Result

IQVIA and Clalit Health Services Partner to Launch First Prime Site in Israel to Advance Research

Sarah Dow by Sarah Dow
November 10, 2022

[ad_1]

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced , announced a long-term cooperation with Clarit. , Israel’s largest healthcare services organization, launched its first prime site in the country.

The partnership will combine IQVIA and Clalit’s capabilities in clinical trial execution, real-world research, data and genomics. Clalit operates a network of 14 hospitals and over 1600 primary care clinics. This healthcare services organization offers a full range of treatments with substantial expertise in, but not limited to, oncology, pediatric rare diseases, and genomics. Combining this expertise, this collaboration will enable us to focus on the future of innovation, such as precision medicine and data-driven testing delivery.

Alistair Grenfell, IQVIA’s President, Europe, Middle East, Africa and South Asia, said: “The work done through this collaboration will transform healthcare and pharmaceutical research in Israel and globally, ultimately improving patient outcomes.”

With IQVIA’s Connected Intelligence™ and Clalit’s mission to transform data insights from electronic medical records into improved policy and better healthcare, this collaboration will position IQVIA as the premier destination for research and innovation in Israel. to ensure that the interest of pharmaceutical companies in Prime Site also ensures that IQVIA can provide in-country solutions to Israeli pharmaceutical and biotech companies.

“Klarit, Israel’s largest medical institution, will leverage Prime Site designation to give patients access to cutting-edge treatments currently in development.” “We will enhance our ability to conduct care research.Through the use of data and the strategic delivery of research and care, our collaboration will help advance our understanding of drug and health care developments in the real world.”

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Through its analytics, innovative technology, big data resources, and broad domain expertise, IQVIA creates intelligent connections across all aspects of healthcare. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility. This enables customers to accelerate the clinical development and commercialization of innovative medicines that improve patient outcomes. With approximately 83,000 employees, IQVIA operates in over 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a variety of privacy-enhancing technologies and safeguards to protect individual privacy while helping healthcare professionals identify disease patterns and correlate them with the precise treatment pathways and treatments needed for better outcomes. We generate and analyze information at scale to help IQVIA’s insights and execution capabilities help biotechs, medical devices, pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders to better understand disease, human behavior, and scientific progress. , to help move you on the road to therapy. For more information, please visit www.iqvia.com.

About Clarit Health Services

Clarit, Israel’s largest and leading insurer, provides lifelong integrated inpatient and outpatient health care services to more than 52% of the Israeli population. We offer a wide range of services through more than 1600 outpatient clinics, 14 public hospitals, and our subsidiaries (Clalit Smile Dental Clinics, Clarit Aesthetics, Clarit Complementary Medicine, and “Mor” Medical Institutes and Services) nationwide. As an innovation-driven organization, Clarit is globally recognized as a pioneer in digital health and data-driven research and innovation hubs, with a particular focus on proactive preventive care and disease that promotes healthy lifestyles. , providing state-of-the-art services worldwide. Country – anytime, anywhere.

For more information, please visit www.clalit.co.il.

View source version at businesswire.com: https://www.businesswire.com/news/home/20221110005815/en/

Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828

Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221

Source: IQVIA

[ad_2]

Source link

Sarah Dow

Sarah Dow

Next Post
AddUp and MT Aerospace Extend Partnership on DED

AddUp and MT Aerospace Extend Partnership on DED

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Pet Insurance That Covers Pre-Existing Conditions – Forbes Advisor
  • Pet Insurance That Covers Pre-Existing Conditions – Forbes Advisor
  • Pros and Cons – Forbes Advisor
  • Home
  • About us
  • Contact us
  • DMCA

© 2022 forbes - Copyrights reserved by Forbes LLC.

No Result
View All Result
  • Home
  • Review
  • Apple
  • Applications
  • Computers
  • Gaming
  • Gear
    • Audio
    • Camera
    • Smartphone
  • Microsoft
  • Photography
  • Security

© 2022 forbes - Copyrights reserved by Forbes LLC.